MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Pancreatic cancer is aggressive, recurrent, and chemoresistant.
• Pancreatic cancer stem cells (PCSCs) drive tumor initiation, resistance, and relapse.
• MicroRNAs (miRNAs) regulate PCSC biology, including self-renewal, pluripotency, and drug resistance.

Purpose of the Study:

• To identify PCSC-specific miRNAs that regulate pluripotency and chemoresistance.
• To validate the function of identified miRNAs in PCSC differentiation and drug sensitivity.

Main Methods:

• Enrichment of PCSCs via pancreosphere culture and FACS sorting.
• MicroRNA microarray analysis to identify differentially expressed miRNAs (DEmiRNAs).
• Validation using RT-qPCR, Western blot, RNA-seq, in vitro assays, and in vivo tumorigenicity studies.

Main Results:

• Identified 31 DEmiRNAs, with 10 downregulated miRNAs linked to pluripotency pathways.
• let-7b-5p and miR-24-3p overexpression inhibited pluripotency pathways and factors in PCSCs.
• These miRNAs induced PCSC differentiation, reduced sphere formation, enhanced gemcitabine sensitivity, and suppressed tumorigenicity.

Conclusions:

• let-7b-5p and miR-24-3p act as tumor suppressors in pancreatic cancer by targeting PCSCs.
• Restoring these miRNAs offers a potential therapeutic strategy to overcome chemoresistance and improve pancreatic cancer outcomes.